Cargando…
Mouse Transplant Models for Evaluating the Oncogenic Risk of a Self-Inactivating XSCID Lentiviral Vector
Hematopoietic stem cell gene therapy requires the use of integrating retroviral vectors in order to stably transmit a therapeutic gene to mature blood cells. Human clinical trials have shown that some vector integration events lead to disrupted regulation of proto-oncogenes resulting in disordered h...
Autores principales: | Zhou, Sheng, Ma, Zhijun, Lu, Taihe, Janke, Laura, Gray, John T., Sorrentino, Brian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633865/ https://www.ncbi.nlm.nih.gov/pubmed/23626802 http://dx.doi.org/10.1371/journal.pone.0062333 |
Ejemplares similares
-
Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes
por: Zhou, Sheng, et al.
Publicado: (2016) -
Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair
por: Koldej, Rachel M, et al.
Publicado: (2009) -
Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins
por: Akgül, Seçkin, et al.
Publicado: (2022) -
Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential
por: Treanor, Louise M., et al.
Publicado: (2014) -
Generation and characterization of an Il2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients
por: Li, Rong, et al.
Publicado: (2020)